Journal Article Summary
The article investigates the effectiveness and safety of Qingfeijianpi therapy for treating persistent allergic rhinitis (AR), a common chronic condition affecting millions worldwide. Allergic rhinitis can significantly impact daily life, work, and school performance, making effective treatment essential. While conventional medications provide quick relief, they often lack long-term benefits, leading to a recurrence of symptoms. This study aims to explore a traditional Chinese medicine approach, Qingfeijianpi therapy, which has been used in clinical practice for a decade but has not been scientifically evaluated until now.
The study involved 101 patients diagnosed with persistent AR, who were randomly assigned to either a treatment group receiving Qingfeijianpi decoction or a control group taking loratadine, an antihistamine. After four weeks of treatment, both groups showed similar improvements in symptoms. However, during a 12-week follow-up, the treatment group demonstrated a more sustained reduction in symptoms compared to the control group. Additionally, the Qingfeijianpi therapy was associated with significant improvements in TCM syndrome scores and quality of life measures, indicating its potential as a long-term treatment option.
Despite the promising results, the study has limitations, including the lack of blinding, which could introduce bias in symptom reporting. The reliance on patient-reported outcomes may also affect the accuracy of the findings. Patients considering this therapy should consult with healthcare professionals to discuss its suitability for their specific condition and any potential interactions with other treatments. Overall, while Qingfeijianpi therapy appears to be a safe and effective option for managing persistent AR, further research is needed to confirm these findings and understand the underlying mechanisms.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Qu Jing, Liu Chang, Lian Hai-Hong, Wang Xiang-Dong, Zhi Nan. Qingfeijianpi therapy for persistent allergic rhinitis. Medicine 2018. DOI: 10.1097/MD.0000000000010961. PMID: 29879045. PMCID: PMC5999516.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
